Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.3800 (-3.29%) ($8.3550 - $8.3800) on Thu. May. 11, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.37% (three month average) | RSI | 69 | Latest Price | $8.3800(-3.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.2% a day on average for past five trading days. | Weekly Trend | BCRX advances 6.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(31%) CEMB(27%) XLRE(24%) BND(23%) EWI(22%) | Factors Impacting BCRX price | BCRX will decline at least -1.685% in a week (0% probabilities). VIXM(-17%) VXX(-16%) TLT(-13%) UUP(-12%) VCIT(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.685% (StdDev 3.37%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.53(-1.76%) | 10 Day Moving Average | $8.21(2.07%) | 20 Day Moving Average | $7.92(5.81%) | To recent high | -19% | To recent low | 13.6% | Market Cap | $1.478b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |